FDA Recalls Heartburn Drug Zantac Due To Cancer Risk
The Food and Drug Administration (FDA) said that people should stop taking all forms of the heartburn drug ranitidine after it appeared with an impurity that may contribute to cancer risk.
Read Original Article: FDA Recalls Heartburn Drug Zantac Due To Cancer Risk »
